These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33282074)

  • 41. Antimicrobial use and antimicrobial resistance in Enterobacterales and Enterococcus faecium: a time series analysis.
    O'Riordan F; Shiely F; Byrne S; O'Brien D; Ronayne A; Fleming A
    J Hosp Infect; 2022 Feb; 120():57-64. PubMed ID: 34780809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repurposing of antibiotics for clinical management of COVID-19: a narrative review.
    Yacouba A; Olowo-Okere A; Yunusa I
    Ann Clin Microbiol Antimicrob; 2021 May; 20(1):37. PubMed ID: 34020659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tackling Antimicrobial Resistance in the Shadow of COVID-19.
    Patel A
    mBio; 2021 Aug; 12(4):e0047321. PubMed ID: 34281392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Making waves: How does the emergence of antimicrobial resistance affect policymaking?
    Maganha de Almeida Kumlien AC; González-Villalobos E; Balcázar JL
    Water Res; 2021 Nov; 206():117772. PubMed ID: 34688095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications.
    Pierce J; Stevens MP
    Int J Infect Dis; 2021 Dec; 113():103-108. PubMed ID: 34624517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The overlooked bacterial pandemic.
    Moriel DG; Piccioli D; Raso MM; Pizza M
    Semin Immunopathol; 2024 Jan; 45(4-6):481-491. PubMed ID: 38078911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
    Clancy CJ; Nguyen MH
    Clin Infect Dis; 2020 Dec; 71(10):2736-2743. PubMed ID: 32361747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?
    Hashmi FK; Atif N; Malik UR; Saleem F; Riboua Z; Hassali MA; Butt MH; Mallhi TH; Khan YH
    Disaster Med Public Health Prep; 2022 Aug; 16(4):1285-1286. PubMed ID: 33691830
    [No Abstract]   [Full Text] [Related]  

  • 50. A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
    Bauer KA; Puzniak LA; Yu KC; Klinker KP; Watts JA; Moise PA; Finelli L; Ai C; Gupta V
    Open Forum Infect Dis; 2022 Nov; 9(11):ofac537. PubMed ID: 36381612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial Resistance & Migrants in Sweden: Poor Living Conditions Enforced by Migration Control Policies as a Risk Factor for Optimal Public Health Management.
    Elisabeth M; Maneesh PS; Katarina SF; Slobodan Z; Michael S
    Front Public Health; 2021; 9():642983. PubMed ID: 34277534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19: Impact on prescribing and antimicrobial resistance.
    Ruiz-Garbajosa P; Cantón R
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):63-68. PubMed ID: 34598431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Building Blocks of Antimicrobial Resistance in
    Langendonk RF; Neill DR; Fothergill JL
    Front Cell Infect Microbiol; 2021; 11():665759. PubMed ID: 33937104
    [No Abstract]   [Full Text] [Related]  

  • 55. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 56. Curbing antimicrobial resistance in post-COVID Africa: Challenges, actions and recommendations.
    Shomuyiwa DO; Lucero-Prisno DE; Manirambona E; Suleman MH; Rayan RA; Huang J; Zaw TN; Babatunde Y; Denkyira SA; Musa SS
    Health Sci Rep; 2022 Sep; 5(5):e771. PubMed ID: 35949681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 58. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper.
    Maillard JY; Bloomfield SF; Courvalin P; Essack SY; Gandra S; Gerba CP; Rubino JR; Scott EA
    Am J Infect Control; 2020 Sep; 48(9):1090-1099. PubMed ID: 32311380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 will further exacerbate global antimicrobial resistance.
    Yam ELY
    J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32539142
    [No Abstract]   [Full Text] [Related]  

  • 60. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.